Atlas of Rheumatoid Arthritis

2015
ISBN: 978-1-907673-90-0
Verlag: Springer Healthcare Ltd.

Buch, Englisch, 264 Seiten, Format (B × H): 148 mm x 210 mm, Gewicht: 366 g

Atlas of Rheumatoid Arthritis is a high-quality educational initiative, written by leaders in the field of rheumatology, containing a collection of approximately 150 relevant images, with extended descriptive captions and a comprehensive bibliography. The Atlas of Rheumatoid Arthritis will provide clinicians with a visual guide to rheumatoid arthritis, focusing on assessment, diagnosis and treatment, including newer research into the signalling pathways involved in the pathogenesis of RA, before focusing on the treatment of RA. Rheumatoid arthritis (RA) is the most common and most serious of the inflammatory arthritic disorders, and it dominates clinical rheumatological practice. Effective, early treatment is vital as this can slow the course of the disease and reduce joint damage. RA is usually treated using disease-modifying anti-rheumatic drugs (DMARDs), most commonly methotrexate. The newest treatments target the disease-causing immune elements specifically and directly.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Emery, Paul

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Rheumatologie, Muskelerkrankungen
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Bildgebende Verfahren, Nuklearmedizin, Strahlentherapie Radiologie, Bildgebende Verfahren

Inhaltsverzeichnis

Classification of rheumatoid arthritis.- Pre-rheumatoid arthritis.- Early rheumatoid arthritis.- Established rheumatoid arthritis.- Remission and rheumatoid arthritis.- Magnetic resonance imaging in rheumatoid arthritis.- Ultrasound imaging in rheumatoid arthritis.- Dual energy X-ray absorptiometry in rheumatoid arthritis.- Methotrexate.- Immunotherapy.- Rituximab.- Novel therapies in rheumatoid arthritis: small molecules.

Über Autor(innen)

Professor Paul Emery is the Arthritis Research UK Professor of Rheumatology and Director of
the Leeds Institute of Rheumatic and Musculoskeletal Medicine and the Director of the Leeds

Musculoskeletal Biomedical Research Unit at Leeds Teaching Hospitals Trust in Leeds, United

Kingdom. Professor Emery was the President of the European League Against Rheumatism

(EULAR) from 2009–2011 and has served on the editorial boards major rheumatology journals

including Rheumatology, Arthritis and Rheumatism, Annals of the Rheumatic Diseases, Clinical

and Experimental Rheumatology, and Clinical Rheumatology. He was the inaugural President of

International Extremity MRI Society (ISEMIR) and is a National Institute for Health Research

(NIHR) Senior Investigator. Professor Emery is a recipient of the Roche Biennial Award for

Clinical Rheumatology; the Rheumatology Hospital Doctor of the Year Award; the EULAR

Prize for outstanding contribution to rheumatology research; and the Carol Nachman Prize

for outstanding rheumatology research. Professor Emery’s research interests center around the

immunopathogenesis and immunotherapy of rheumatoid arthritis, spondyloarthritis, and connective

tissue diseases. He has a special interest in the factors leading to persistent inflammation

and has published over 950 peer-reviewed articles in this area.

is the Arthritis Research UK Professor of Rheumatology and Directorof
the Leeds Institute of Rheumatic and Musculoskeletal Medicine and the Director of the Leeds

Musculoskeletal Biomedical Research Unit at Leeds Teaching Hospitals Trust in Leeds, United

Kingdom. Professor Emery was the President of the European League Against Rheumatism

(EULAR) from 2009–2011 and has served on the editorial boards major rheumatology journals

including Rheumatology, Arthritis and Rheumatism, Annals of the Rheumatic Diseases, Clinical

and Experimental Rheumatology, and Clinical Rheumatology. He was the inaugural President of

International Extremity MRI Society (ISEMIR) and is a National Institute for Health Research

(NIHR) Senior Investigator. Professor Emery is a recipient of the Roche Biennial Award for

Clinical Rheumatology; the Rheumatology Hospital Doctor of the Year Award; the EULAR

Prize for outstanding contribution to rheumatology research; and the Carol Nachman Prize

for outstanding rheumatology research. Professor Emery’s research interests center around the

immunopathogenesis and immunotherapy of rheumatoid arthritis, spondyloarthritis, and connective

tissue diseases. He has a special interest in the factors leading to persistent inflammation

and has published over 950 peer-reviewed articles in this area.